The Efficacy of Citalopram Treatment in Acute Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 642 participants.
Also called NCT01937182
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 642 participants
- Sponsor
- Registry
-
NCT01937182
-
- Other papers using this trial's data
- Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark
- Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT01937182. Randomized; quadruple masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2016-12-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of Citalopram Treatment in Acute Stroke
- Acronym
- TALOS
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Citalopram
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Aarhus
- Collaborator
- Danish Council for Independent Research
- Collaborator
- The Danish Regions Medicine Foundation
Record details
- Record id
cardio:ct-nct01937182- Content hash
1ac8e829c6e562349f66dceaf83bcea880ca632d399ffb188b399d333330f549